Generating AI analysis...
AI Earnings Analysis
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Revenue | $58.84M | $44.58M | +32.00% |
Cost of Revenue | $45.24M | $42.59M | +6.22% |
Operating Income | $-479M | $-350.06M | -36.83% |
Net Income | $-463.66M | $-328.07M | -41.33% |
EPS (Basic) | $-1.69 | $-1.58 | -6.96% |
EPS (Diluted) | $-1.69 | $-1.58 | -6.96% |
R&D Expense | $314.42M | $241.23M | +30.34% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Total Assets | $1.45B | $653.7M | +121.60% |
Current Assets | $714.27M | $438.14M | +63.02% |
Total Liabilities | $413.82M | $190.26M | +117.50% |
Current Liabilities | $187.47M | $93.17M | +101.21% |
Stockholders' Equity | $1.03B | $463.44M | +123.28% |
Cash & Equivalents | $594.35M | $391.56M | +51.79% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Cash Flow | $-359.17M | $-287.78M | -24.81% |
Investing Cash Flow | $260.06M | $-10.23M | +2642.62% |
Financing Cash Flow | $304.12M | $140.13M | +117.02% |
D&A | $36.49M | $24.4M | +49.55% |
| Metric | Current | Previous | YoY Change |
|---|---|---|---|
Operating Margin | -814.1% | -785.3% | -28.76% |
Net Margin | -788.0% | — | — |
ROE | -44.8% | — | — |
ROA | -32.0% | — | — |
Current Ratio | $3.81 | — | — |
Debt to Equity | $0.4 | — | — |
Other companies in Biotechnology